about
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuumA Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease RiskFBXW7 mutations in melanoma and a new therapeutic paradigmGene expression microarrays: glimpses of the immunological genome.Genetic similarity between cancers and comorbid Mendelian diseases identifies candidate driver genes.Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.GAB2 induces tumor angiogenesis in NRAS-driven melanoma.An information theoretic method to identify combinations of genomic alterations that promote glioblastoma.Foxp3 Transcription-Factor-Dependent and -Independent Regulation of the Regulatory T Cell Transcriptional Signature
P50
Q24594356-8B7F5704-D46C-401B-A917-F46086805B68Q30002401-17048BBB-507F-4AC5-A5D1-7B704D053864Q33845217-BBC31F2A-569F-4775-946F-9D8C5062752AQ34540065-1EA067DF-FB93-41E2-A72C-94B812B775B8Q35559086-04C30B18-A736-432C-8806-BF3629758AA9Q36024310-67D181B8-6B16-4F12-BA29-2FE4B4349627Q37270065-FC7E1688-C911-4248-B3A5-FBF4C9224B3AQ40976160-1E5C1696-6C3E-411E-BC19-0CD04A74F4E5Q61713917-87BFD31D-2066-4071-AFB3-89D5DB7BC7F9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rachel D Melamed
@ast
Rachel D Melamed
@en
Rachel D Melamed
@es
Rachel D Melamed
@sl
type
label
Rachel D Melamed
@ast
Rachel D Melamed
@en
Rachel D Melamed
@es
Rachel D Melamed
@sl
prefLabel
Rachel D Melamed
@ast
Rachel D Melamed
@en
Rachel D Melamed
@es
Rachel D Melamed
@sl
P106
P21
P31
P496
0000-0003-3089-9806